H.R. 2212 - CREATES Act of 2017
- Sponsor:
- Tom Marino
- Summary:
- To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. (by CRS)
- Status:
- The bill has been referred to committee.
CREATES Act of 2017
H.R. 2212 — 115th Congress (2017–2018)
- Summary
- To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. (by CRS)
- Learn More
- At OpenCongress
- Title
- To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
- Other Titles
- CREATES Act of 2017
- CREATES Act of 2017
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- CREATES Act of 2017
- Sponsor
- Tom Marino
- Co-Sponsors
- Andy Barr
- Dave Brat
- David N. Cicilline
- Steve Cohen
- John Abney Culberson
- Peter A. DeFazio
- Lloyd Doggett
- John J. Duncan, Jr.
- Mike Gallagher
- Bob Gibbs
- Glenn Grothman
- Marcy Kaptur
- Peter T. King
- Daniel Lipinski
- Mark Meadows
- Eleanor Holmes Norton
- Beto O’Rourke
- Jamie Raskin
- James B. Renacci
- Todd Rokita
- Francis Rooney
- Janice D. Schakowsky
- Carol Shea-Porter
- Bennie G. Thompson
- Peter Welch
- Subjects
- Health
- Civil actions and liability
- Drug safety, medical device, and laboratory regulation
- Licensing and registrations
- Prescription drugs
- Product development and innovation
- Related Bills
- Major Actions
Introduced 4/27/2017 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 4/27/2017 4/27/2017 Introduced in House 4/27/2017 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 4/28/2017 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
support this bill
Pharmaceutical manufacturing | $7,750,369 |
Republican/Conservative | $7,128,642 |
Physicians | $6,949,716 |
Hospitals | $4,963,452 |
Accident & health insurance | $3,668,820 |
HMOs | $2,736,820 |
Pharmaceutical wholesale | $2,181,407 |
Department, variety & convenience stores | $1,952,309 |
Drug stores | $1,307,252 |
Pharmacists | $938,398 |
Health care services | $809,683 |
Health, Education & Human Resources | $653,855 |
Health & welfare policy | $297,323 |
Labor Unions | $77,443 |
Elderly issues/Social Security | $74,352 |
Consumer groups | $20,500 |
Fiscal & tax policy (split) | |
$41,510,341 |
oppose this bill
Fiscal & tax policy (split) | |
$0 |
Contributions data source: OpenSecrets.org